The largest insider transaction on today’s list is a Form 4 filing by Artal Group, which reported a purchase of roughly $40.4 million in Lexicon Pharmaceuticals $LXRX.
Artal Group now owns 83,835,950 LXRX shares, representing a roughly 47.5% ownership stake.
There was also another Form 4 in Lexicon Pharmaceuticals filed by Director Raymond Debbane, who disclosed a purchase of roughly $2,456,500.
Reginald J. Brown, independent director at Blackstone $BX, disclosed a purchase of 3,100 shares, equivalent to $307,985 in his company’s stock in a Form 4.
Here’s The Hot List, with data through August 1, 2022:
The only 13D on our list was filed by Impactive Capital LP, which revealed an ownership stake of 9% in SLM Corporation $SLM.
Robert Stallings, an Independent director of Texas Capital Bancshares $TCBI, revealed an additional purchase of 4,000 shares of stock, as he continues to build a position.
In the options market, there was bullish flow in the social media app Pinterest $PINS and the small-cap biotech company Altimmune $ALT.
Stay tuned. We’ll be back Wednesday with more insider action.
If you want these insider transactions e-mailed to you every morning, click here to sign up for The Hot Corner.
And please reach out with any questions. We love hearing from you!
All Star Charts Team